Nurshat Abdolla

Nurshat Abdolla

Auto-generated profile, based on publicly available information

Nurshat Abdolla

M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2017 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
NBNikolai Belyaev
Nikolai Belyaev
NANurshat Abdolla
Nurshat Abdolla
YPYuliya V. Perfilyeva
Yuliya V. Perfilyeva
YOYekaterina Ostapchuk
Yekaterina Ostapchuk
VKVladimir K. Krasnoshtanov
Vladimir K. Krasnoshtanov
RTRaikhan Tleulieva
Raikhan Tleulieva

24 September 2018 in Inflammation
Verified
Journal Article
Closed access
PDF file
YPYuliya V. Perfilyeva
Yuliya V. Perfilyeva
NANurshat Abdolla
Nurshat Abdolla
YOYekaterina Ostapchuk
Yekaterina Ostapchuk
RTRaikhan Tleulieva
Raikhan Tleulieva
VKVladimir C. Krasnoshtanov
Vladimir C. Krasnoshtanov
NBNikolai N. Belyaev
Nikolai N. Belyaev

28 April 2017 in Inflammation Research
Verified
Journal Article
Closed access
PDF file
YPYuliya V. Perfilyeva
Yuliya V. Perfilyeva
NANurshat Abdolla
Nurshat Abdolla
YOYekaterina Ostapchuk
Yekaterina Ostapchuk
RTRaikhan Tleulieva
Raikhan Tleulieva
VKVladimir C. Krasnoshtanov
Vladimir C. Krasnoshtanov
NBNikolai N. Belyaev
Nikolai N. Belyaev

1 May 2025 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
YPYuliya V. Perfilyeva
Yuliya V. Perfilyeva
AKAikyn Kali
Aikyn Kali
DADiana S. Aben
Diana S. Aben
YAYulduz R. Abdusattarova
Yulduz R. Abdusattarova
ALAnzhelika V. Lushova
Anzhelika V. Lushova
NANurshat Abdolla
Nurshat Abdolla

4 March 2023 in Eurasian Journal of Ecology
Verified
Journal Article
Open access
ALA Lushova
A Lushova
SKS Kan
S Kan
AZAndrey Victorovich Zhigailov
Andrey Victorovich Zhigailov
YOYekaterina Ostapchuk
Yekaterina Ostapchuk
SKS Kuatbekova
S Kuatbekova
SMSeidigapbar Mamadaliyev
Seidigapbar Mamadaliyev
Bovine viral diarrhea (BVD) is an acute infectious disease caused by BVD virus (BVDV). BVD is characterized by fever, lesions of the mucosal lining of the digestive tract, diarrhea, conjunctivitis and rhinitis. This disease is considered as one of the most dangerous infectious diseases in animal husbandry worldwide because of its high prevalence, persistence in the environment, and severe clinical consequences. The purpose of this study is to assess the epizootological situation on BVD of cattle, which has developed by the beginning of 2021 in various regions of the Republic of Kazakhstan. For this purpose, we retrospectively analyzed samples of cattle serum collected in 2018-2020 by ELISA for the presence of antibodies to BVDV in them. It was found that BVD in cattle was prevalent even before 2021 in a significant area of Kazakhstan, while the total seroprevalence for BVDV was 67.3% (243/361; 95% CI: 0.37-0.63). Among the animals from which serum was taken, 51.2% of the animals were vaccinated with BVDV vaccines and 48.8% of the animals were unvaccinated. The average seroprevalence of antibodies to BVDV in unvaccinated animals was 36.4% (64/176; 95% CI: 1.2-2.5) positive samples were detected in unvaccinated animals in Zerenda, Astrakhan, Tselinograd and Shortanda districts of Akmola region, also in Akzhar and Kyzylzhar districts of North Kazakhstan region and Aksu district of Almaty region. The results obtained contribute to the disclosure of the epizootological situation of BVD in the territory of Kazakhstan, which will allow the full use of effective control measures, such as total vaccination of livestock in the risky regions of the infection and the introduction of strict restrictive measures to prevent further spread of the infection to other regions of the country. Keywords: Bovine viral diarrhea, cattle, enzyme immunoassay, Pestivirus, Togaviridae.

13 January 2025 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
GNGulzhan Narmuratova
Gulzhan Narmuratova
YMYerdan Mukhaliyev
Yerdan Mukhaliyev
JDJude T. Deeney
Jude T. Deeney
MNMeiramkul Narmuratova
Meiramkul Narmuratova
NANurshat Abdolla
Nurshat Abdolla
Obesity is a widespread chronic inflammatory disease that can lead to increased health risks and subsequent development of prediabetes and type 2 diabetes. According to the World Obesity Federation (WOF), the prevalence of obese individuals in the world will increase to 1 billion adults by 2030. The WOF includes Kazakhstan as a high-risk country for obesity. In 2030 obesity in Kazakhstan is predicted to reach 25.7% in men, 29% in women, and 9.5% in children aged 5-19. The National Center for Public Health of the Republic of Kazakhstan has reported a significant increase in the prevalence of overweight and obesity, particularly among children. According to the results of epidemiological monitoring, the rate of obesity among boys was notably higher than that among girls. Specifically, 23.6% of boys were classified as overweight, including obesity, compared to 17.6% of girls. Additionally, 8.7% of boys were classified as obese, compared to 4.6% of girls [1,2]. Recent studies highlight the role of immune cell function in obesity-related inflammation providing a potential new target for treating obesity-linked inflammatory diseases. This review article discusses the role of immune cells in regulating obesity-related diseases, including diabetes.